Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
anticonvulsants
anticonvulsants, effectiveness
autoantibodies
autoantibody prevalence in epilepsy score
autoimmune disease
autoimmune epilepsy
heralding manifestation
immunotherapy
neurologic disease, diagnoses of
seizure
seizure, drug resistance
seizure, etiology of
seizure, focal
seizure, intractable
seizure, prevalence of
seizure, unknown origin
Showing articles 1300 to 1350 of 4658 << Previous Next >>

Cerebral Venous Sinus Thrombosis Presenting in Pregnancy and Puerperium
BMJ Case Re doi:10.1136/bcr.06.2009.2045, Dangal,G. & Thapa,L.B., 2009

Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
J Natl Cancer Inst 101:946-958, Armstrong,G.T.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Practice Parameter: Evaluation of the Child with Microcephaly (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 73:887-897, Ashwal,S.,et al, 2009

Epilepsy in Children with Infantile Thiamine Deficiency
Neurol 73:828-833, Fattal-Valevski,A.,et al, 2009

Diagnosis and Therapy in Neuromuscular Disorders: Diagnosis and New Treatments in Mitochondrial Diseases
JNNP 80:943-953, Rahman,S. &Hanna,M.G., 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Obesity Is a Common Comorbidity for Pediatric Patients with Untreated, Newly Diagnosed Epilepsy
Neurol 73:658-664, 654, Daniels, Z.S.,et al, 2009

Functional and Cognitive Outcome in Prolonged Refractory Status Epilepticus
Arch Neurol 66:1505-1509, Cooper,A.,et al, 2009

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Arch Neurol 66:1334-1338, 1322, Suzuki,S.,et al, 2009

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

The Value of Specifying Brand-Name Antiepileptic Drugs
Arch Neurol 66:1415-1416, 1418, Ng,Y., 2009

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

A Multicenter, Prospective Pilot Study of Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy: Seizure Response, Adverse Events, and Verbal Memory
Ann Neurol 65:167-175, Barbaro,N.M.,et al, 2009

Neurosarcoidosis: A Study of 30 New Cases
JNNP 80:297-304, Joseph,F.G. &Scolding,N.J., 2009

Clinicopath Conf, Multiple Bilateral Cerebral Infarcts with Intracerebral Hemorrhage in Reversible Cerebral Vasoconstrictive Syndrome
NEJM 360:1126-1137, Case 8-2009, 2009

Community-Acquired Bacterial Meningitis in Elderly Patients: Experience Over 30 Years
Medicine 88:115-119, Cabellos,C.,et al, 2009

Clinicopath Conf. Rickets Due to Vitamin D Deficiency
NEJM 360:398-407, Case 3-2009, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009

Clinicopath Conf., Adult Cerebral Form of X-Linked Adrenoleukodystrophy
NEJM 360:171-181, Case 1-2009, 2009

Persistent Fainting After Implantation of a "Curative" Pacemaker
NEJM 360:88-89, Kasim,S.,et al, 2009

Diagnostic Usefulness of the ABCD Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events: The North Dublin TIA Study
Stroke 40:3449-3454, Sheehan,O.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Seizure Relapse and Development of Drug Resistance Following Long-Term Seizure Remission
Arch Neurol 66:1233-1239, Schiller,Y., 2009

Can the ABCD Risk Score Predict Positive Diagnostic Testing for Emergency Department Patients Admitted for Transient Ischemic Attack?
Stroke 40:3202-3205, Schrock,J.,et al, 2009

The Present Efficacy of Multiple Sclerosis Therapeutics
Neurol 73:984-990, Klawiter,E.,et al, 2009

Slurred Speech and Spirochaetes
Lancet 373:978, Thukral,A.,et al, 2009

Unexplained Seizures in an Infant
Lancet 373:94, Astuto,M.,et al, 2009

NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009

Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Detection of Human Herpesvirus-6 in Cerebrospinal Fluid of Patients with Encephalitis
Ann Neurol 65:257-267,235, Yao,K.,et al, 2009

Community-Acquired Bacterial Meningitis in Elderly Patients: Experience over 30 Years
Medicine 88:115-119, Cabellos,C.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009



Showing articles 1300 to 1350 of 4658 << Previous Next >>